264 related articles for article (PubMed ID: 17618628)
1. Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method.
Andújar-Sánchez M; Jara-Pérez V; Cámara-Artigas A
FEBS Lett; 2007 Jul; 581(18):3449-54. PubMed ID: 17618628
[TBL] [Abstract][Full Text] [Related]
2. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.
Andújar-Sánchez M; Cámara-Artigas A; Jara-Pérez V
Biophys Chem; 2004 Oct; 111(2):183-9. PubMed ID: 15381315
[TBL] [Abstract][Full Text] [Related]
3. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme.
Natesh R; Schwager SL; Evans HR; Sturrock ED; Acharya KR
Biochemistry; 2004 Jul; 43(27):8718-24. PubMed ID: 15236580
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.
Natesh R; Schwager SL; Sturrock ED; Acharya KR
Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design.
Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR
J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442
[TBL] [Abstract][Full Text] [Related]
6. An ACE structure.
Hooper NM; Turner AJ
Nat Struct Biol; 2003 Mar; 10(3):155-7. PubMed ID: 12605218
[No Abstract] [Full Text] [Related]
7. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
[TBL] [Abstract][Full Text] [Related]
8. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme.
Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843
[TBL] [Abstract][Full Text] [Related]
11. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.
Zidane F; Zeder-Lutz G; Altschuh D; Girardet JM; Miclo L; Corbier C; Cakir-Kiefer C
Biochemistry; 2013 Dec; 52(48):8722-31. PubMed ID: 24168709
[TBL] [Abstract][Full Text] [Related]
12. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.
Skirgello OE; Binevski PV; Pozdnev VF; Kost OA
Biochem J; 2005 Nov; 391(Pt 3):641-7. PubMed ID: 16033330
[TBL] [Abstract][Full Text] [Related]
13. Development of domain-selective angiotensin I-converting enzyme inhibitors.
Redelinghuys P; Nchinda AT; Sturrock ED
Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
[TBL] [Abstract][Full Text] [Related]
14. Effect of peptide-based captopril analogues on angiotensin converting enzyme activity and peroxynitrite-mediated tyrosine nitration.
Bhuyan BJ; Mugesh G
Org Biomol Chem; 2011 Jul; 9(14):5185-92. PubMed ID: 21629912
[TBL] [Abstract][Full Text] [Related]
15. Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme.
Pina AS; Roque AC
J Mol Recognit; 2009; 22(2):162-8. PubMed ID: 18816584
[TBL] [Abstract][Full Text] [Related]
16. Structure of human ACE gives new insights into inhibitor binding and design.
Brew K
Trends Pharmacol Sci; 2003 Aug; 24(8):391-4. PubMed ID: 12915047
[TBL] [Abstract][Full Text] [Related]
17. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.
Perich RB; Jackson B; Johnston CI
Eur J Pharmacol; 1994 Feb; 266(3):201-11. PubMed ID: 8174603
[TBL] [Abstract][Full Text] [Related]
18. Studies on the Interaction between Angiotensin-Converting Enzyme (ACE) and ACE Inhibitory Peptide from Saurida elongata.
Lan X; Sun L; Muhammad Y; Wang Z; Liu H; Sun J; Zhou L; Feng X; Liao D; Wang S
J Agric Food Chem; 2018 Dec; 66(51):13414-13422. PubMed ID: 30511571
[TBL] [Abstract][Full Text] [Related]
19. Structure of angiotensin I-converting enzyme.
Sturrock ED; Natesh R; van Rooyen JM; Acharya KR
Cell Mol Life Sci; 2004 Nov; 61(21):2677-86. PubMed ID: 15549168
[TBL] [Abstract][Full Text] [Related]
20. In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I-converting enzyme inhibitory activity.
Vukic VR; Vukic DV; Milanovic SD; Ilicic MD; Kanuric KG; Johnson MS
Nutr Res; 2017 Oct; 46():22-30. PubMed ID: 29173648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
